Abstract
Cholestyramine, a bile-binding agent, markedly inhibited the development of gastric lesions induced by water-immersion stress in rats and of gastric and intestinal lesions induced by indomethacin in rats and dogs with an intact pylorus. However, cholestyramine had no effect on gastric lesions induced by stress in pylorus-ligated rats and on aspirin-induced gastric lesions in rats and dogs with or without pylorus ligation. Hydrotalcite, a potent antacid, significantly inhibited the gastric lesions induced by stress and aspirin in rats and dogs with or without pylorus ligation. Hydrotalcite also inhibited the gastric lesions induced by a single administration of indomethacin in rats with an intact pylorus. In contrast, the agent had no effect on gastric and intestinal lesions induced by repeated administration of indomethacin to rats and dogs with an intact pylorus. These results suggest that while bile probably plays an important role in the pathogenesis of stress-induced gastric lesions and of indomethacin-induced gastric and intestinal lesions, bile does not appear to play a role in the pathogenesis of aspirin-induced gastric lesions.
Similar content being viewed by others
References
du Plessis DJ: Pathogenesis of gastric ulceration. Lancet 1:974–978, 1965
Rhodes J, Barnardo DE, Phillips, SF, Rovelstad RA, Hofmann AF: Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 57:241–252, 1969
Capper WM, Airth GR, Kilby JO: A test for pylorus regurgitation. Lancet 2:621–623, 1966
Davenport HW: Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 54:175–181, 1968
Ivey KJ, DenBesten L, Clifton JA: Effect of bile salts on ionic movement across the human gastric mucosa. Gastroenterology 59:683–690, 1970
Black RB, Hole D, Rhodes J: Bile damage to the gastric mucosal barrier: The influence of pH and bile acid concentration. Gastroenterology 61:178–184, 1971
Hamza KN, DenBesten L: Bile salts producing stress ulcers during experimental shock. Surgery 71:161–167, 1972
Braun SA, Samson RH, Norton L, Eiseman B: Bile reflux in experimental stress ulcer. Surgery 71:521–524, 1973
Mersereau WA, Hinchey EJ: Prevention of bile reflux-induced acute gastric ulceration in the rat by cholestyramine. Ann Surg 179:883–888, 1974
Mann NS: Bile-induced acute erosive gastritis. Its prevention by antacid, cholestyramine, and prostaglandin E2. Am J Dig Dis 21:89–92, 1976
Schumpelick V, Grossner D: Cholestyramine zur Stressulcus-Prophylaxe der Ratte. Res Exp Med 166:235–239, 1975
Zike WL, Safaie-Shirazi S, Paluska G, DenBesten L: The role of cholestyramine in the prevention of stress ulcers. Gastroenterology 64:826, 1973
Ritchie WP, Shearburn EW: Influence of isoproterenol and cholestyramine on acute gastric mucosal ulcerogenesis. Gastroenterology 73:62–65, 1977
Norton L, Mathews D, Avrum L, Eiseman B: Pharmacological protection against swine stress ulcer. Gastroenterology 66:503–508, 1974
Clain JE, Malagelada JR, Chadwick VS, Hofmann AF: Binding properties in vitro of antacids for conjugated bile acids. Gastroenterology 73:556–559, 1977
Playle AC, Gunning SR, Llewellyn AF: Thein vivo antacid and anti-pepsin activity of hydrotalcite. Pharm Acta Helv 49:298–302, 1974
Mendelsohn D, Mendelsohn L: Hydrogen ion, pepsin and bile acid binding properties of hydrotalcite. S. Afr Med J 49:1011–1014, 1975
Takagi K, Okabe S: The effects of drugs on the production and recovery processes of the stress ulcer. Jpn J Pharmacol 18:9–18, 1968
Takeuchi K, Okabe S, Takagi K: A new model of stress ulcer in the rat with pylorus ligation and its pathogenesis. Am J Dig Dis 21:782–788, 1976
Okabe S, Takeuchi K, Nakamura K, Takagi K: Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rat. Jpn J Pharmacol 24:363–371, 1974
Hung CR, Takeuchi K, Okabe S, Murata T, Takagi K: Effects ofl-glutamine on acetylsalicylic acid induced gastric lesions and acid back diffusion in dogs. Jpn J Pharmacol 26:703–709, 1976
Tabata K, Okabe S: Effects of 16, 16-dimethyl prostaglandin E2 methyl ester on aspirin- and indomethacin-induced gastrointestinal lesions in dogs. Dig Dis Sci 25:439–448, 1980.
Anson ML: The estimation of pepsin, trypsin, papain and cathepepsin with hemoglobin. J Gen Physiol 22:79–89, 1938
Okabe S, Hung CR, Takeuchi K, Takago K: Effects ofl-glutamine on acetylsalicylic acid or taurocholic acid-induced gastric lesions and secretory changes in pylorus-ligated rats under normal or stress conditions. Jpn J Pharmacol 26:455–460, 1976
Hemmati M, Abtahi F, Farrokhsiar M, Djahanguiri B: Prevention of restraint and indomethacin-induced gastric ulceration by bile duct or pylorus ligation in rats. Digestion 10:108–112, 1974
Kitagawa H, Fujiwara M, Osumi Y: Effects of waterimmersion stress on gastric secretion and mucosal blood flow in rats. Gastroenterology 77:298–302, 1979
Okabe H, Takeuchi K, Urushidani T, Takagi K: Effects of cimetidine, a histamine H2-receptor antogonist, on various experimental gastric and duodenal ulcers. Am J Dig Dis 22:677–684, 1977
Lee YH, Mollison KW, Cheng WD: The effects of anti-ulcer agents on indomethacin-induced gastric ulceration in the rat. Arch Int Pharmacol Ther 192:370–377, 1971
Kasuya Y, Urushidani T, Okabe S: Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jpn J Pharmacol 29:670–673, 1979
Wax J, Clinger WA, Varner P, Bass P, Winder CV: Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 58:772–780, 1970
Takemoto K, Tanaka K: Inhibitory effect of cholestyramine on the intestinal ulcer formation in rats given an antiphlogistic agent. Gastroenterology 67:765–766, 1974
Brodie DA, Cook PG, Bauer BJ, Dagle GE: Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol 17:615–624, 1970
Gallo DG, Bailey KR, Sheffner AL: The interaction between cholestyramine and drugs. Proc Soc Exp Biol Med 120:60–65, 1965
Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR: Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 153:237–249, 1966
Guth PH, Paulsen G, Lynn D, Aures D: Mechanism of prevention of aspirin-induced gastric lesions by bile duct ligation in the rat. Gastroenterology 71:750–753, 1976
Davenport HW: Salicylate damage to the gastric mucosal barrier. N Engl J Med 276:1307–1312, 1967
Gottschalk A, Menguy R: Role of gastric acid in aspirin-induced erosive gastritis. Proc Soc Exp Biol Med 135:384–388, 1970
Brodie DA, Chase BJ: Role of gastric acid in aspirin-induced gastric irritation in the rat. Gastroenterology 53:604–610, 1967
Eder HA: Drugs used in the prevention and treatment of atherosclerosis.In The Pharmacological Basis of Therapeutics. Goodman LS, Gilman A (eds.). New York, Macmillan, 1975, pp 748–749
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ishihara, Y., Okabe, S. Effects of cholestyramine and synthetic hydrotalcite on acute gastric or intestinal lesion formation in rats and dogs. Digest Dis Sci 26, 553–560 (1981). https://doi.org/10.1007/BF01308106
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01308106